↓ Skip to main content

Cochrane Database of Systematic Reviews

Ribavirin monotherapy for chronic hepatitis C

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
98 Mendeley
Title
Ribavirin monotherapy for chronic hepatitis C
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd005527.pub2
Pubmed ID
Authors

Jesper Brok, Lise Lotte Gluud, Christian Gluud

Abstract

Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 15%
Researcher 12 12%
Student > Master 12 12%
Student > Ph. D. Student 10 10%
Student > Postgraduate 8 8%
Other 19 19%
Unknown 22 22%
Readers by discipline Count As %
Medicine and Dentistry 35 36%
Agricultural and Biological Sciences 8 8%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 13 13%
Unknown 29 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2020.
All research outputs
#3,945,445
of 19,965,580 outputs
Outputs from Cochrane database of systematic reviews
#6,529
of 12,006 outputs
Outputs of similar age
#64,254
of 333,376 outputs
Outputs of similar age from Cochrane database of systematic reviews
#155
of 247 outputs
Altmetric has tracked 19,965,580 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,006 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.8. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 247 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.